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ABSTRACT Unbinding pathways of retinoic acid (RA) bound to retinoic acid receptor (RAR) have been explored by the random
expulsion molecular dynamics (REMD) method. Our results show that RA may exit the binding site of RAR through ﬂexible
regions close to the H1-H3 loop and b-sheets, without displacing H12 from its agonist position. This result may explain kinetic
differences between agonist and antagonist ligands observed for other nuclear receptors. The extended and ﬂexible structure of
RA initiated a methodological study in a simpliﬁed two-dimensional model system. The REMD force should in general be dis-
tributed to all atoms of the ligand to obtain the most unbiased results, but for a ligand which is tightly bound in the binding pocket
through a strong electrostatic interaction, application of the REMD force on a single atom is preferred.
INTRODUCTION
The retinoic acid receptor (RAR) acts as a transcriptional
factor together with the retinoid X receptor, mediating the
effect of retinoic acid (RA), which regulates cellular pro-
liferation and differentiation in vertebrates. Both receptors
belong to the nuclear hormone receptor family, comprising
many important drug targets. Rational drug design aimed at
these receptors includes the nontrivial task of accurately
estimating the afﬁnity of the ligand binding domain for small
molecule ligands. Computational techniques for estimating
the afﬁnity range in complexity from empirical scoring func-
tions (1) to explicit evaluations of the absolute free energy of
binding (2). Equally important properties in the drug devel-
opment process are selectivity and efﬁcacy; and resolution
of the free energy of binding into its kinetic components
(on- and off-rates) may provide a way of understanding and
predicting these phenomena (3). Speciﬁcally, experimental
studies of binding kinetics based on the surface plasmon
resonance technique show distinct separation of on-rates be-
tween estrogen receptor agonists and antagonists (4). Thus,
detailed knowledge of how ligands enter and exit the re-
ceptor adds useful information to the drug development
process. Theoretical modeling of kinetic constants requires
identiﬁcation and characterization of the binding pathways to
ﬁnd the most plausible routes for the ligand from solvent to
binding pocket.
A crystallographic structure model of receptor with bound
ligand offers a well-deﬁned starting point for identiﬁcation
of unbinding pathways. Assuming microscopic reversibility,
the results from an unbinding simulation are valid also for
the reverse process. Molecular dynamics (MD) simulations
describe the evolution over time of a system in atomic detail,
but the application of MD on macromolecular systems is
severely limited by the short time ranges (tens of nanosec-
onds) which are routinely accessible today. Biologically rel-
evant events such as rearrangement of tertiary structure in
proteins or ligands entering a binding site typically occur on
a much longer timescale and will therefore not be observed
in ordinary MD simulations. Several techniques have been
presented to overcome this limitation, e.g., locally enhanced
sampling molecular dynamics (ESMD) (5), steered molec-
ular dynamics (SMD) ((6) and references therein), and ran-
dom expulsion molecular dynamics (REMD) (7).
In REMD, an artiﬁcial force of constant magnitude acting
on the bound ligand is added to the standard force ﬁeld to
accelerate the unbinding process. The direction of the force is
randomly varied to ensure that the ligand searches for many
possible escape routes during a relatively short timespan.
REMD was developed on and successfully applied to cyto-
chrome P450 systems (7) but suggested to be generally
applicable to ligand-receptor systems.Originating from simu-
lations of atomic force microscopy applications, SMD is an
alternative approach which also applies an artiﬁcial force to a
speciﬁc part of the system but in a predetermined direction.
SMD was used to study the unbinding of RA from RAR (6),
and several plausible binding routes for the ligand were
investigated. SMD allows a more detailed mapping of the
energy proﬁle along the speciﬁed pathway compared to
REMD but is limited in ligand-binding studies by the sub-
jective choice of pathway direction. Consequently, Lu¨demann
et al. used REMD for an unbiased search for pathways (7) and
followed up the analysis by applying SMD on the resulting
pathways (8).
In this work, we describe the application of REMD to study
unbinding of RA from RAR. Our focus is on the identiﬁca-
tion of pathways and evaluation of a computational method
not previously applied to the nuclear hormone receptor fam-
ily. The RAR system was selected for several reasons. First,
conclusions from this model should be applicable to other
nuclear receptors, including many important drug targets,
due to the highly conserved tertiary structure within this
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superfamily. Second, this system has been studied with
alternative computational techniques (6,9), allowing meth-
odological comparisons. Third, the extended and ﬂexible
nature of RA in combination with the presence of a strong
electrostatic interaction with the receptor is a challenge for the
REMD method and would enhance our understanding of the
application of REMD. Last, high quality starting structures are
available through the Protein Data Bank (10). The physical
characteristics of RA prompted us to undertake a speciﬁc
study of the REMD methodology as applied to this type of
ligand. For this purpose we constructed a minimal two-
dimensional (2D) model system in which the inﬂuence of pa-
rameters such as force application scheme, intrinsic ﬂexibility,
and charge state could be controlled. The very small number
of particles in this model system enabled extensive testing
because of the short simulation times required. Conclusions
from this study assisted interpretation of our results from the
full RAR model.
MATERIALS AND METHODS
Protein model
The RAR model was based upon the coordinates of the Protein Data Bank
entry 2LBD, including human RAR, all-trans RA, and 119 crystallographic
water molecules (11). Hydrogen atoms were added by the HBUILD (12)
command in CHARMM (13). The structure was relaxed to the CHARMM22
(14) all-atom force ﬁeld by two rounds of adopted-basis Newton-Raphson
minimization: ﬁrst 500 steps with all a-carbons harmonically restrained (force
constant 20.0 kcal/mol/A˚2) followed by 1500 steps without restraints. The
complex was solvated in a 20-A˚-radius sphere of TIP3P (15) water, where all
noncrystallographic water molecules having the oxygen atom closer than 2.8
A˚ of any protein atoms were removed. A very brief, unconstrained steepest
descent minimization for 20 steps ﬁnalized themodel setup. SHAKEwas used
to constrain bond lengths and angles during the MD simulations.
Two-dimensional model system
Carbon atoms of type CT3 (14) were used to deﬁne a ligand and a wall or a
cage (Fig. 1, a and b). The uncharged wall and cage atom centers were
placed 5.0 A˚ apart, not connected to each other, and positionally restrained
by a harmonic potential (force constant 5.0 kcal/mol/A˚2). The ligand was
modeled by 4, 7, or 15 carbon atoms arranged as an extended alkane chain,
using C-C bond lengths and C-C-C angles from the force ﬁeld. The ligand
atoms had no partial charge unless otherwise stated. A circular boundary
potential was used in the wall model to continue the ligand movements in
the x, y plane. Verlet dynamics was carried out with all coordinates and
velocities in the z-direction zeroed.
MD simulation details
For nonbonded interactions the potential energy and force were smoothly
shifted to zero at 12.0 A˚, and a 14.0-A˚ nonbonded list generation cutoff was
used. To obtain variation in a given setup, simulations were restarted 30–50
times with varying random speeds for the initial assignment of velocities.
REMD was implemented as looping short MD simulations by high-level
scripting in CHARMM. The REMD force on the ligand was added to the
force ﬁeld, selecting the carbon atom number 6, 10, or 15 in the ligand (C6,
C10, and C15, respectively) (Fig. 2).
In the initial setup of the RAR model, harmonic positional restraints
where set on helix 9 of the RAR receptor model, residues 348–370. Partial
atomic charges for the RA ligand were derived by Gaussian 94 (16) for the
rigid ligand structure using the HF/6-31G* basis set and the electrostatic
potential (ESP) (17) charge-ﬁtting algorithm. Force ﬁeld parameters for RA
are listed in the Supplementary Material (Tables S1 and S2). In the initial
setup the tolerance for energy change between MD steps was set to 2000
kcal/mol, and a time step of 0.002 ps was used.
In the ﬁnal setup the constraints were moved to residues 325–336, which
correspond to helix 8 in the RAR model. The initial HF/6-31G* RA ligand
charges were restrained by the RESP (18) program as provided from the
AMBER home page (19) to average charges on methyl group hydrogen
atoms and reduce the overall magnitude of partial charges. It was assumed
that this procedure yielded a sufﬁciently accurate electrostatic description of
the ligand for use in conjunction with a strong external force. A stronger
REMD force was used, up to 2000 pN, and the energy change tolerance level
was set to 200 kcal/mol. The time step was decreased to 0.001 ps.
REMD-speciﬁc parameters
The magnitude of the REMD force was set to 10–30 pN per atom in the
ligand, corresponding to 500–1000 kJ/mol/nm as applied on the center of
mass of camphor by Lu¨demann et al. (7). In our initial simulations, intervals
of N ¼ 10, 20, and 30 MD steps (N) were tested. The velocity of the ligand
was periodically evaluated as the average velocity over the last N steps. The
variation in key results such as fraction of successful expulsions was very
small, and a ﬁxed interval of 20 steps (20 fs) was used throughout the ﬁnal
FIGURE 1 Initial conﬁgurations of the 2D model system. (a). The wall
model. Ten carbon atoms are placed along the x axis, forming an atomic wall
separating the positive and negative y axis half-planes. A gap may be opened
by removing atoms (open) at the middle (central gap) or at the side positions
(distal gap). A steeply rising spherical boundary potential centered in the
origin creates a circular boundary in the x, y plane, which limits the ligand
movements to an area near the origin. The atoms at the ends of the mole-
cule are deﬁned as head (H)/tail (T) of the ligand. (b) The cage model. The
circular potential is replaced by an extension to the wall, forming a cage
(dark), which roughly resembles a wide binding pocket. The height of the
cage may be adjusted to ﬁt the length of the ‘‘ligand’’ (pale).
FIGURE 2 Schematic structure of all-trans RA. The atom labeling is indi-
cated with C for carbon and O for oxygen. Force ﬁeld parameters are listed
in the Supplementary Material (Tables S1 and S2).
3152 Carlsson et al.
Biophysical Journal 91(9) 3151–3161
simulation setup. The initial minimum velocity of Ævæmin ¼ 2 3 104 A˚/fs
led to very few changes of directions, and therefore the limit was increased
ﬁvefold to 1 3 103 A˚/fs. The REMD simulation was aborted either when
the ligand atom C6 had moved more than 26 A˚ from the starting position
(approximately the radius of the receptor protein) or when the maximum
simulation time of 200 ps was reached.
RESULTS
Development of RAR model for REMD simulations
Experiences from previous MD studies of nuclear receptors
(20,21) guided our setup of a RAR model for REMD simu-
lations. RAR was solvated in a spherical water droplet to
enable complete solvation of surface residues with a limited
number of water molecules. The starting structure with the
12 helices (H1-H12) fold possessed characteristic receptor-
ligand interactions as described for the crystallographic
structure (see Fig. 4, a and d) (11). The important Arg-278,
Ser-289, and Phe-288 contacts with the ligand were all pres-
ent, and ligand binding pocket (LBP) residues on H1, H3,
H5, and the b-turn were also within van der Waals (vdW)
contact distance of the ligand.
In our early attempts to apply a REMD force to the ligand,
we noted that the protein molecule was prone to translate and
rotate due to the external force, and therefore we found it
necessary to restrain the receptor in the water sphere. Strong
positional restraints (force constant 10.0 kcal/mol/A˚2) on the
a-carbon atom of the most central residue (Ile-270) were
tested to prevent translation but allow the protein to rotate and
thereby possibly facilitate expulsion through a curved path-
way. However, all of these attempts resulted in failed sim-
ulations due to excessive energy changes between MD steps.
A contrasting approach using weak restraints (force constant
0.1 or 0.01 kcal/mol/A˚2) on all a carbons resulted in fewer
failures but also very few successful expulsion events. Ini-
tially, the most successful scheme was to apply moderate
restraints (force constant 1.0) on the a carbons of the distal
H9, residues 348–370. This helix is far from the binding site
as well as far from previously suggested pathways near H12
(6) and H7 (22). In the ﬁnal setup for the RAR model, the
central H8 (residues 325–336) was restrained instead of H9,
since recent simulations of the structurally related glucocor-
ticoid receptor (20) show that this is the least ﬂuctuating helix.
The optimal magnitude of the REMD force is a compro-
mise between high expulsion efﬁciency (high force) and
minimal structural distortion (low force), which we moni-
tored by the change in total energy of the system in one MD
step. Finding parameters which yield a reasonable number of
expulsions within a given time limit, without violation of the
energy change tolerance criterion, turned out to be nontrivial.
To allow a sufﬁciently large REMD force necessary for the
charged ligand with MD parameters close to the default
values, the time step was reduced from 0.002 to 0.001 ps, but
still a large number of simulations failed due to large energy
changes between successive MD steps in the initial setup. A
detailed examination of the model revealed large ﬂuctuations
in intermolecular electrostatic energies, and therefore the
inﬂuence of various charge schemes was investigated. These
are summarized in Table 1. The deprotonated ligand with
6-31G*/ESP charges, which was our starting point, yielded a
large number of aborted simulations due to violation of the
energy tolerance. Protonation of the carboxylic moiety of
RA reduced the magnitude of the partial charges in the
carboxylic end of the ligand. This ligand model yielded no
expulsions when a weak force (200–500 pN) was applied to
C6 or C15 and 100% violation of the energy change toler-
ance criterion when a force of 750 pN was used. Increasing
the energy change tolerance 1000-fold to 20,000 kcal/mol
led to successful expulsions in all cases with protonated RA
and 750-pN pull force on C6 or C15. To clarify if the charge-
charge interactions between RA and protein residues caused
these rapid energy changes, a completely uncharged, pro-
tonated RA was tested. With 750-pN force and default energy
change threshold of 20 kcal/mol no simulations crashed, and
60–90% yielded ligand expulsion within 200 ps. The same
setup for a deprotonated RA using restrained electrostatic
potential (RESP) charges based on 6-31G* calculations re-
sulted in few expulsions, even during 400 ps of simulation,
but no energy violation. Further methodological discussion
about the default MD parameters in a REMD simulation is
given in Supplementary Material Part S4.
The external force used in REMD can be partitioned over
all ligand atoms or applied to a single atom of the ligand.
This choice may have consequences for the results, espe-
cially when the ligand is charged, ﬂexible, or structurally
extended. RA exhibits all these characteristics, and therefore
we investigated both application of the partitioned REMD
force on all atoms of RA, including hydrogen atoms, as well
as application of the full force on various single atoms (C6,
C10, or C15, respectively). Preliminary (initial set up) results
TABLE 1 Summary of conditions tested during system setup
Charges Protonated Deprotonated
No charges 750/20: 60–90% exp. 1000/20: 20% exp., no crashes
6-31G*/ESP 200–500/20: no exp. 750/20: all crashed 750/20,000: 100% exp. Starting point using several protocols: few exp.
6-31G*/RESP Not tested 750/20: few exp., no crashes 1000–2000/200: main setup
Charge models are explained in the Materials and Methods section. Simulations are described as REMD force (pN)/threshold (kcal/mol): result. The
threshold is the maximum allowed change in energy between successive MD steps, and the ‘‘crashes’’ refers to simulations that were aborted due to violation
of this threshold. The result is expressed as percentage successful expulsions (exp.). ‘‘Starting point’’ refers to the initial setup and ‘‘Main setup’’ to the ﬁnal
conditions used in this study.
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showed a slightly higher expulsion frequency for pulling at
atom C15, the carbon in the carboxylic moiety, than for force
application on C6 or C10. Some ligand expulsions resulting
from application of the force on a single atom involved un-
physical ligand movements and conformations, which initi-
ated a detailed methodological study on a smaller 2D model
system. Such a study would help us separate methodological
effects from system-speciﬁc results. To what extent does a
certain force application mode bias the ligand movement
toward a particular pathway? How does a strong electrostatic
interaction inﬂuence the expulsion frequency, and does the
location of this interaction relative to the pathway affect the
results?
The two-dimensional model system
The details of the wall and cage geometries (Fig. 1, a and b)
are given in the Materials and Methods section. Our model
ligand was a carbon atom chain of varying length where the
parameters for bond lengths, angles, and vdW radius were
taken from aliphatic carbons in the force ﬁeld. The expulsion
ratio was measured as the fraction of successful expulsions
from 30–50 simulations for every new parameter setup. A
rough error estimate for the expulsion ratio based on the
standard deviation in repeated simulation series is 5%
(Supplementary Material, Table S3).
The simplest model system consisted of a wall with a gap
and a ligand restrained by a circular potential (Fig. 1 a).
Three ligand sizes were tested (4, 7, and 15 atoms), and the
gap was positioned at the center of the wall. For each ligand,
three different simulations were carried out: ordinary MD
without REMD force, REMD with the force distributed on
all atoms, or REMD with the external force applied to one
atom at the end of the molecule. The successful expulsion
ratios are presented in Table 2. Our results from the centered
gap simulations show that the force application mode is of
minor importance for small ligands, whereas the expulsion
ratio is increased from 70% to nearly 100% for the extended
ligands when the force application is changed from all atoms
to a single atom. In the centered gap model it is easier to pull
out a large ligand when the force is applied to one atom.
Small ligands tumble around in the model cavity and there-
fore exhibit a lower expulsion frequency. Note that in this
model the ends of the ligand are initially equally far from
the exit gap. Typically the ligands will rotate and exit with
the pulled atom ﬁrst. This is particularly pronounced for the
large ligand where all expulsions take place in this manner.
In addition, the comparison with ordinary MD shows that
REMD is particularly efﬁcient when applied to large ligands.
To evaluate the intrinsic likelihood of the ligand being
pulled out head ﬁrst or pushed out tail ﬁrst relative to where
the REMD force is applied, the gap was moved to the far
end of the wall near the boundary imposed by the circular
potential. The results are presented in Table 3. Moving the
gap to the far end of the artiﬁcial binding pocket where it is
closer to one end of the ligand did not change the expulsion
frequencies. Instead, the effect was seen in the head ﬁrst ratio
of the large ligand where all the ligands now exited with the
atom closest to the exit gap (head atom) rather than with their
pulling atom. For the medium sized ligand, the pulling atom
was still the most frequently leading atom upon expulsion,
and the same, although less pronounced, was valid for the
smallest ligand.
The role of ligand ﬂexibility was studied by changing the
force constants for bond angle and torsion angle parameters
(Table 4). To achieve a very rigid ligand, standard force
constants were multiplied by 100. The other extreme, a very
ﬂexible ligand molecule, was obtained by setting the angle
force constants to zero. The 2D model system results showed
the highest expulsion frequency when the ligand was ﬂexible
and the REMD force was applied to a single atom (97%), and
the lowest expulsion frequency was observed for a rigid
ligand when using an all-atom force application mode (13%).
The basic 2D model was extended to simulate a more
realistic binding pocket by building a cage of wall atoms.
This provided a tighter compartment for the ligand and
prohibited the tumbling motions observed for the smaller
ligands in the ﬁrst 2D model. It also enabled us to mimic the
strong attractive electrostatic interaction of the carboxylic
end of RA in the RAR binding pocket by charging one atom
TABLE 2 REMD simulation in basic 2D model with central gap
Expulsion ratio (%) Head ﬁrst ratio (%)
Ligand Ligand
Method C4 C7 C15 C4 C7 C15
MD 44 62 0 – – –
REMD (all atom) 72 70 70 36 57 46
REMD (head) 70 61 96 71 90 98
REMD (tail) 60 70 90 17 14 0
Expulsion ratio is the number of successful expulsions to the number of
simulations (n ¼ 50) during a ﬁxed simulation time (200 ps). The initial
position of the ligand is parallel to thewall, andwe design the end of the ligand
nearest to the gap as the ‘‘head’’. Head ﬁrst ratio is the number of expulsions
where the ligand exits through the gap head ﬁrst, to the total number of
expulsions. Random diffusion through the gap would be expected to give
50% head ﬁrst ratio. Ordinary MD without an external force is compared to
threeREMDsetupswhere the external force is applied to all atoms, or a single
atom at either end (‘‘head’’ and ‘‘tail’’, respectively).
TABLE 3 REMD simulation in basic 2D model with distal gap
Expulsion ratio (%) Head ﬁrst ratio (%)
Ligand Ligand
Method C4 C7 C15 C4 C7 C15
MD – – – – – –
REMD (all atom) 50 64 98 44 43 98
REMD (head) 63 74 92 48 84 100
REMD (tail) 63 61 98 35 40 100
REMD simulations (n ¼ 50) of the ‘‘wall’’ model where the gap is
asymmetrically located near the circular boundary.
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in the cage and ligand, respectively, with opposite partial
charges. Resulting expulsion ratios (Table 5) showed that
force application on the charged atom of the ligand signif-
icantly increases the probability of expulsion compared to any
other force application mode. A ligand with an electrostatic
charge interaction close to an exit site is easier to expel with
REMD, as compared to a ligand with an electrostatic inter-
action at a site distal from the exit gate.
Expulsion pathways in RAR
The escape routes of RA from RAR were observed in the
ﬁnal setup clustered in four distinct pathways, labeled A–D
(Fig. 3). The inﬂuence of force application mode on these
pathways is summarized in Table 6. Variation of the REMD
force between 1000 and 2000 pN/ligand atom yielded
consistent results in terms of pathways, but the distortion of
the protein structure varied. The most frequently observed
pathway was found in the ﬂexible area between H3 and the
H1-H3 loop (Pathway A, Fig. 4 b). A variety of routes within
this pathway was observed, with some preference for a
route toward the loop rather than the H3 surface. The ﬂexible
nature of this part of the receptor allowed a considerable
spread of routes, both horizontally and vertically. The recep-
tor structure was well conserved during expulsion through
this direction. Two groups of residues are involved in the
unbinding along pathway A. In a route above the b-sheets
the ligand is within contact of the H1-H3 loop residues
Thr-200, Pro-202, and Leu-207; H3 residues Lys-240 and
Lys-236; and S1 residue Ser-286. An expulsion under the
b-sheets causes the ligand to pass H3 residues Leu-226, Asp-
228, Lys-229, and Ser-231 and H6-H7 loop residue Gly-303.
In both routes, Asp-290 in the S1-S2 loop was in contact
with the escaping ligand. Water attached to the carboxylic
site in the initial structure accompanies the ligand through
its way out of the receptor and is released when the ligand
reaches the solvent shell.
Expulsion along pathway A is the only pathway that was
observed with all force application modes (Table 6). The
ligand exits the receptor with the pulling atom ﬁrst, which in
the case of force application on the middle atom C10 gives a
bent ligand conformation. Application of the REMD force
on the carboxyl carbon atom of the ligand (RA atom 15)
TABLE 4 REMD simulation in basic 2D model with different
ﬂexible ligands
Expulsion ratio (%)
All atom Head
Default parameters 70 96
1003 force constants 13 57
03 force constants 76 97
Expulsion ratios (n ¼ 30) for ligands of extreme ﬂexibility. The ‘‘wall
model’’ (Fig. 1 a) with centered gap and a 15-atom ligand was used. The
REMD force was applied to either all atoms or to a single end atom
(‘‘head’’). The force constants for bond angles and torsion angles in the
ligands were multiplied by 100 and 0 (zero) to simulate a very stiff and a
very ﬂexible ligand, respectively. The default angle parameters used for
alkane chains can be regarded as ﬂexible in the context of REMD as
implemented in this study.
TABLE 5 REMD simulation in 2D cage model with
electrostatic interactions
Expulsion ratio (%)
REMD force applied to
Electrostatic conﬁguration All atoms Head (exit) Tail (inner)
Neutral 100 100 90
Exit charge 46 59 46
Inner charge 26 26 45
Expulsion ratios (n ¼ 30) for REMD on 2D ‘‘cage model’’ (Fig. 1 b). The
largest ligand with 15 atoms is used. In the neutral simulation, all atomic
charges were zero. In the nonneutral simulations, a single atom in the cage
has a partial charge (10.7 e) in the innermost wall (‘‘inner charge’’) or at
the exit gap (‘‘exit charge’’), and the nearest atom of the ligand has a
corresponding partial charge of 0.7 e.
FIGURE 3 Ligand expulsion pathways in RAR as observed in REMD
simulations. Top view of pathways A–D. For each pathway, a typical route
has been marked with the trace of the ligand C6 atom. The receptor top has
been removed for clarity.
TABLE 6 Summary of expulsion ratios for all observed
pathways in the RAR model
Expulsion ratio (%)
REMD force applied to
Expulsion pathway C6 C10 C15
A 58 93 81
B – 7 19
C 25 – –
D 17 – –
See text for detailed descriptions of the various pathways (Fig. 3).
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resulted in ligand escapes almost solely along this pathway,
and in all cases the carboxyl end escaped ﬁrst.
A second pathway was found between H7, the b-sheet
loop, and the H1-H3 loop (Pathway B, Fig. 4 e). This part of
the receptor is denser, but still the b-sheet loop and the H1-
H3 loop provided sufﬁcient receptor ﬂexibility. Pathway B
was observed when the REMD force was applied to C10 or
C15, but at low frequencies. During expulsion along path-
way B, mainly H5 and S1 residues such as Thr-277, Thr-280,
and Thr-287 were within 3.0 A˚. The ligand also passes by the
charged Arg-278 and polar Ser-289, crucial for the initial
positioning of the ligand in the LBP through the interaction
with the RA carboxyl group. Initially attached water mole-
cules stay in close interaction with the ligand during unbind-
ing through pathway B.
A third and unexpected exit pathway was observed in the
sterically crowded region between the b-sheet, H7, and H8
(Pathway C, Fig. 4 f). Escapes along this pathway often
caused major rearrangements of the local receptor structure
since the ligand had to make way for its exit (Fig. 5 a). This
pathway was observed only when the force was applied to
RA atom C6. Expulsion along pathway C involved contacts
with a number of residues in H5 (Leu-273 and Cys-276) and
H7 (Phe-312, Ala-315, Gly-316, and Leu-319) residues.
Also Met-286 in S1 and residues at the loop connecting
H5-S1 are contacted (Tyr-279 and Pro-281). The escape
through pathway C causes a reduction of the solvent inter-
actions at the ligand carboxy end. The initially attached water
molecules stay in the LBP, whereas the ligand is expelled
through the narrow pathway.
Finally, ligand escapes via the long and narrow cleft
between H11 on one side, and H6, H7, and the beginning of
H3 on the other side (Pathway D, Fig. 4 c) were also ob-
served in the ﬁnal setup of the RAR model. These expulsions
caused a shift of 15 A˚ at the beginning of H3 and the H1-H3
loop (Fig. 5 b). Escapes along this pathway only occurred
when the force was applied to RA atom C6 and always
caused large deformations of the receptor structure. The
contacted residues are located in H3, both in the LBP (Phe-
230, Ser-231, Ala-234, and Ile-238) and along the exit
pathway (Ala-302, Gly-303, Pro-409, and Ile-412). Water
molecules in the initial structure are left in the LBP as the
ligand moves out through pathway D.
DISCUSSION
Unbinding pathways in RAR
The majority of our simulations results in ligand expulsion
along pathway A (Table 6). In this ﬂexible part of the re-
ceptor, RA can ﬁnd an exit without major changes of the
overall protein structure. Pathway A is directed parallel to the
initial ligand orientation, and the carboxylic end of the ligand
exits ﬁrst. Water molecules accompany the ligand through its
way out shielding the charged carboxy end in hydrophobic
passages. According to the results of our 2D model simu-
lations, the choice of pathway is biased toward the end of
the ligand where the REMD force is applied. Therefore, we
expect pathway A to be overrepresented when the REMD
force is applied to C15. However, also application of the
FIGURE 4 (a) Front view of initial structure of RAR with ligand (space
ﬁll). (b) Pathway A, RA atom C6 position during the expulsion is displayed
as a trace (space ﬁll). RAR is in its initial position and the ﬁnal position of
the ligand (wire frame) as a molecule. (c) Pathway D, RAR is in its initial
position. (d) Side view of initial structure of RAR with ligand. (e) Pathway
B, RAR is in its initial position. (f) Pathway C, RAR is in its initial position.
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REMD force to atom C6 most frequently leads to exits
through pathway A, although the methodological bias would
underestimate its probability. Thus, we feel conﬁdent in
considering pathway A as the most likely exit pathway found
in this study.
Our pathway A is similar to a possible exit pathway
suggested by Kosztin et al. (6). Their SMD characterization
of this pathway shows a low energy proﬁle and little receptor
deformation compared to a pathway similar to our pathway
D as well as a proposed entry site between H11 and H12
which was never observed in our simulations. In the pro-
posed mechanism for ligand escape via pathway A as deﬁned
by Kosztin et al. (6), the carboxyl end exits ﬁrst. No attempt
to rotate the ligand molecule before the expulsion was made.
In contrast, our results indicate that both the RA head (C6)
and tail (C15) might be the ﬁrst parts to exit. The former case
suggests an alternative binding mechanism where the car-
boxylate end of RA is attracted to the polar ‘‘window’’ (6)
on the receptor surface and anchored by electrostatic inter-
actions, followed by an incorporation of the b-ionone ring
into the hydrophobic LBP driven by desolvation of RA.
Given this order of events, the forced unbinding by this mech-
anism observed in our simulations seems less likely than the
binding of RA through this pathway, thus suggesting path-
way A to be an entry pathway. In any case, this region of
the nuclear receptor structure has also been proposed to host
a ligand binding/unbinding pathway for 3,5,39-L-triiodothy-
ronine to the thyroid hormone receptor (22,23).
Pathway B, which is located on the other side of the H1-H3
loop, is similar to pathway A but more sterically hindered,
resulting in a narrower and less varied pathway. Exit through
pathway B is less frequently observed in our simulations and
to our knowledge not previously described for RAR. How-
ever, recent modeling studies have proposed the existence of
an alternative binding pocket of nuclear receptors (24)
related to the fast biological functions observed for some nu-
clear receptors. The kinetics for the fast biological response
is several orders of magnitude faster than the genomic
response and may therefore require a more accessible LBP.
Speciﬁcally, for the vitamin D receptor and the estrogen
receptor, the alternative LBP was proposed to be located
between the H1-H3 loop and the b-hairpin loop. Interest-
ingly, this would correspond to the portal of our pathway B,
and it is feasible that ligands which are transiently bound
to the alternative LBP occasionally enter the classic LBP
through this pathway.
Pathway C is found in a sterically dense region of the
receptor. The observed exit frequency for this pathway is low
and only observed while pulling the ligand at atom C6 in the
b-ionone ring of RA. Due to the limited space, initially
attached water molecules are left in the LBP. This desolva-
tion should increase the energy proﬁle for this pathway. The
protein is severely deformed in these simulations, especially
in the region close to the exit pathway where both the sheet
section and the H7 move ;5 A˚ (Fig. 5 a). Our simulations
involving pathway C indicate an unphysical unbinding se-
quence where the hydrophobic part of RA enters the solvent
before the hydrophilic end, or a binding sequence where the
carboxylic moiety is buried in the hydrophobic interior of the
protein before the entry of the hydrophobic part of RA, and
may therefore be an artifactual result of the strong REMD
force. In contrast to pathway A, no electrostatic ﬁeld is pres-
ent in this region which could guide the association of the
ligand-receptor complex. More physically sensible is a bind-
ing mechanism where the b-ionone ring enters the hydro-
phobic interior through pathway C, and the position of the
carboxylate near Arg-278 is subsequently obtained by a
rearrangement of the ligand position within the LBP. This
rearrangement could in principle be shared with the initial
step of the two-state unbinding mechanism along pathways
near H11 and H12, as suggested by others (5).
Pathway D was only occasionally observed in the ﬁnal
setup but more frequently in the initial setup. We believe that
the reduced energy tolerance levels of the main setup limit
FIGURE 5 Schematic drawings of the pathways where
substantial protein conformational changes were observed
in our REMD simulations. The initial RAR structures are
represented by dashed lines, and the ﬁnal RAR structures
are shown in solid lines and shaded secondary elements.
Black arrows indicate expulsion pathways. (a) Pathway C,
distance analysis showed that CA of Tyr-279 (solid circle)
has moved 5.3 A˚ and Gly-305 CA (solid circles with
dashed lines) 5.0 A˚. (b) Pathway D, distance analysis
showed that the front (H1-H3 with intervening loop and
H12) has been affected by the REMD force. The CA of
Ser-231 (solid circle with dashed lines) has moved almost
19 A˚, whereas the CA of Leu-224 (solid circle) has moved
14 A˚.
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the number of expulsion events through this pathway, which
requires large structural rearrangements. However, our 2D
model simulations indicate that this pathway is disfavored
due to the application of the REMD force on an atom far
from the exit and suggest that the actual frequency may be
twofold higher than the observed frequency (see below).
Kosztin et al. (6) also try to unbind RA through this pathway,
but RA never leaves the receptor interior during a 750-ps
simulation despite several attempts to vary the direction of
the applied force and considerable deformation of the re-
ceptor structure. The linear pathway implied by SMD might
not be appropriate if the exit route has a curved nature.
REMD could in principle ﬁnd curved pathways, but still
pathway D is observed at a low frequency and the receptor
structure is severely affected (Fig. 5 b).
In this study, our focus has been to identify all possible
escape pathways and our REMD simulations do not allow a
detailed quantiﬁcation of the likelihood of each proposed
pathway. The large conformational changes observed for
pathways C and D show that ligand escape is sterically pos-
sible along these pathways, but due to the short simulation
time they do not represent equilibrated conformations. Sup-
port for the existence of the proposed pathways comes from
experimental studies on several nuclear receptors where
point mutations of amino acids along our pathways have
been shown to affect receptor function in general and bind-
ing kinetics in particular. Our pathway D exits between the
H11-H12 loop and the N-terminal half of H3, and in this
region mutations are studied in the estrogen receptor (25,26),
the glucocorticoid receptor (27,28), the androgen receptor
(29), and the thyroid hormone receptor (30). Many of these
mutations comprise residues which govern the interaction
between the H11-H12 loop and H3 and could therefore also
modulate the binding kinetics for a pathway such as our path-
way D. Further support comes from studies by Gee and
Katzenellenbogen (31), who showed that the estrogen receptor
may undergo partial unfolding in the LBP region. It was
hypothesized that this transient conformational change inﬂu-
ences ligand binding, and as such, the partial unfolding may
confer larger conformational changes than observed for our
pathway D.
Ligand expulsion effect on helix 12
H12 never leaves the canonical agonist position (32) in our
REMD simulations, although it is not artiﬁcially constrained
to this position. Since the REMD methodology does not
favor any particular direction, we expected H12 to be pushed
away if that would lead to a favorable unbinding pathway for
the ligand in addition to the trivial case where H12 is dis-
placed from the agonist position leaving the LBP wide open.
Instead, the ligand ﬁnds several other ways out of the LBP in
our simulations. Reversing the unbinding process, our results
suggest that it is possible for an agonist ligand to bind to a
nuclear hormone receptor inwhichH12 is already positioned in
the agonist conformation. We believe that this could explain
observations of large differences in on-rates between estrogen
receptor agonist and antagonist ligands (4). Possibly, the larger
antagonist ligands can only enter the binding site when H12
is not bound to the receptor surface in the agonist position
as postulated by the mouse trap mechanism (11), whereas
agonists may bind virtually any nonliganded conformation of
the receptor. This is in line with the conformational selection
model (33–35) where ligands continuously sample an ensem-
ble of protein conformations and ligand binding results in
selective stabilization of certain conformations leading to a
shifted equilibrium of the conformational ensemble. In this
model, antagonist ligands would sample a smaller subset of
conformations, i.e., face a lower effective concentration of
appropriate receptors, thus having a lower association rate.
The similar results from our REMD simulations and the
SMD simulations by Kosztin et al. (6) are somewhat con-
trasted by ESMD results (9) where RA exits from RAR
exclusively via pathway D, and the unbinding involves a two-
step mechanism involving ligand dissociation from speciﬁc
interactions in the LBP followed by a protein reorganization
phase. Crucial for unbinding through this mechanism is the
detachment of H12, which is not observed in our model or
mentioned in the work by Kosztin et al. (6). The different
results can be method dependent or model dependent. The
ESMD method is conceptually similar to REMD in using an
increased temperature factor for the ligand, and it is evident
that the accelerated motion of the ligand affects the protein
structure in bothmethods, but probably in different ways. The
use of a single ligand copy in REMD causes a distinct effect
on the protein structure at the collision site, whereas the
multiple ligand copies in ESMD should lead to a more wide-
spread protein-ligand interaction. Possibly the more broadly
distributed but weaker protein-ligand interactions of ESMD
simultaneously destabilize many interactions around the
LBP, which eventually leads to the detachment of H12 mak-
ing the exit pathway D more likely. The differences between
these investigations can also be sought in theRARmodel. The
ESMD simulations were based on a homology model of the
RAR receptor without addition of structural water molecules.
Later, it has been shown that structural water molecules may
indeed bridge H12 to the rest of the RAR receptor and thereby
slow down the dissociation rate considerably (36). In a more
recent ESMD study of the thyroid hormone receptor three
ligand unbinding pathways are found, two of which do not
require opening of H12 (22). All three pathways, however,
deform various parts of the secondary structure.
Somewhat counterintuitive, the strong force used in our
REMD simulations may actually be the reason for the limited
deformation of the overall protein structure. Whereas indi-
vidual side chains are mobile and quickly react to sterical
changes in their surroundings, the secondary structure
elements along the observed pathways may not have time
to react to the rapidly moving ligand on the subnanosecond
timescale. Indeed, the strong REMD force applied in this
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study makes most of our escape routes nearly straight (Fig.
3). To fully utilize the inherent capability of the REMD
method to explore curved escape routes, one would need to
remove strong electrostatic interactions which require a large
force to break. A smaller force in a system dominated by
weak short-range interactions would result in a greater
probability for the ligand of halting and changing directions.
In this context, it would be of interest to compare proposed
pathways in different systems for ligands of varying size
relative to its receptor. In our case, the ligand is approx-
imately equal in size to a single secondary structure element
such as a b-strand or a medium sized a-helix. Such large
ligands may have predominantly linear routes to and from
buried binding sites, whereas small ligands such as diatomic
gases in myoglobin may more frequently use more compli-
cated routes possibly involving intermediate binding sites.
The overall shape of escape routes would then essentially be
determined by the magnitude of the conformational change
required for ligand travel.
Residues involved in the unbinding process
Imperative for an informative REMD simulation is a phys-
ically relevant starting structure, where protein-ligand inter-
actions are consistent with available experimental data.
However, the magnitude of the artiﬁcial force in REMD is
much larger than the normal intermolecular interactions be-
tween ligand and receptor, and therefore we can only qual-
itatively judge the importance of individual residues located
along the unbinding pathway using this method. We noted
that the characteristics of the contacted amino acids differ
along the four pathways. Along pathway A, there is a mix of
polar, charged, and hydrophobic residues. PathwayB exhibits
a highly hydrophilic character. Expulsion through this part of
the receptor involves several charged and polar side chains,
which suggests that solvent may play an important role for
ligand expulsion in these directions. Pathways C and D are
mainly lined by hydrophobic amino acids.Residues contacted
along pathway C have rather small side chains, which may
be required for ligand expulsion through this dense region of
the receptor.
Effect of ligand size and force application site
The RAR system we are interested in differs from the
cytochrome P450 system which Lu¨demann et al. (7) studied
ﬁrst by REMD in several ways. Our primary concern was the
RA ligand, which has an extended conformation with more
ﬂexibility than camphor, the main ligand in the cytochrome
P450 study. Lu¨demann et al. included the extended ligand
palmitoleic acid and noted that it required a signiﬁcantly larger
rupture force due to the strong charge-charge interaction
between the acid moiety and the protein, but it is not clear how
and to what extent the ﬂexible and extended structure of this
ligand inﬂuenced the outcome of the REMD simulation.
Should the force be applied to the center of mass or to
individual atoms? Will application of force at one end of the
ligand bias the result? How should the strong charge-charge
interaction best be handled? To be able to study these kinds of
questions we used a 2D model system, which offered precise
control over simulation parameters and very short simulation
times compared to the full three-dimensional protein model.
For an extended and somewhat ﬂexible ligand, we ex-
pected different results when the force was distributed to all
atoms compared to application of the full force on a single
atom. The all-atom force distribution is, from a technical
viewpoint, the same as application of the force to the center
of mass. In terms of expulsion frequency, this is consistent
with our observations of the basic 2D system as shown in
Table 2. Whereas the small ligands are expelled in 60–70%
of the simulations, independent of force application scheme,
the expulsion ratio is increased from 70% to nearly 100% for
the longest ligand when the force is applied to a single atom.
As expected, application of the REMD force on one atom
makes this atom the leading atom, and expulsion of the
ligand will therefore take place with this atom ﬁrst. We can
interpret this by an analogy: it is easier to pull a trailer for-
ward with your car, than reversing. The smaller ligands (4
and 7 atoms, respectively) are probably too small to have an
effective ‘‘trailer’’, whereas the longest ligand has effectively
one trailer in each direction when the REMD force is dis-
tributed evenly. When the force is distributed to all atoms,
the orientation by which the ligand exits the gap is more
random and close to 50% for both ends. This shows that our
2D model works as expected and sets a standard for expul-
sion ratios for further experiments.
REMD was developed to overcome the problem of sam-
pling events such as ligand binding and unbinding that
normally take place on timescales much longer than ordinary
MD simulations. In our model system, we expected a very
small ligand molecule to be able to diffuse out through the
gap, essentially unhindered, whereas a large ligand should be
trapped. Our results from the 2D simulations show that both
the 4-atom ligand and the 7-atom ligand may diffuse out
during an ordinary 200-ps MD simulation, whereas the longer
ligand needs the assistance from an external force to pass the
gap within that time. In this study, the magnitude of the
REMD force has simply been scaled to the number of atoms
in the ligand, independent of atom types. In the 2D model
there is only one atom type, but when including hydrogen
atoms as in the full protein model, inverse weighting of the
force to the atomic mass may be an alternative. However,
limited tests with realistic small molecules in our 2D model
setting showed no marked differences such as structural
deformations due to exaggerated forces on hydrogen atoms,
which is why this may be a relatively minor issue.
The expulsion ratio is slightly decreased for the small
ligands when the gap is moved to the far end of the wall
(Table 3), whereas the largest ligand increases its ratio
to almost 100% expulsion also with a distributed force. A
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plausible explanation is that the smaller ligands may tumble
freely in the relatively large cavity deﬁned by the wall and
circular potential, but when the gap is in the middle of the
wall, the small ligands have only about half the space for
tumbling before they are likely to hit the gap. All expulsions
with the largest ligand take place head ﬁrst, showing that
there are no complete rotations, thus the ligand mainly
moves back and forth or follows the cavity borders.
Ligand ﬂexibility and electrostatic interactions
Increasing the angular and dihedral force constants to create
a more rigid ligand decreases the expulsion ratio (Table 4). A
very rigid ligand has a lower expulsion frequency compared
to a more ﬂexible one, indicating that a certain degree of
ﬂexibility facilitates expulsion. This effect is particularly
pronounced when the force is distributed over all ligand
atoms. In contrast, for a ﬂexible ligand the highest expulsion
frequency is achieved when the REMD force is applied on a
single atom. Our results indicate that an alkane chain built
on standard force ﬁeld parameters can be considered to be
completely ﬂexible in this context.
The introduction of a charged site in the system strongly
decreases the expulsion frequencies, as seen in our 2D
‘‘cage’’ model (Table 5). The lowest expulsion rates are ob-
served when the charge is placed at the interior of the system,
opposite to the exit. Our results clearly show that the easiest
way to disrupt an electrostatic interaction and get ligand
expulsion is to apply the REMD force on the charged atom.
Force application to other atoms resulted in lower expulsion
frequency at the same level. Consequently, the exit closest to
the charge will be favored, and in our 2D model study the
expulsion ratio was;1:2 for the inner versus the exit charge,
respectively. The actual frequency of escapes along a path-
way where the ligand is anchored by an inner charge may
therefore be underestimated by a factor of 2.
To summarize, our REMD simulations showed that the
force application mode is a critical parameter for the outcome
of a REMD simulation. A single atom application is pre-
ferred if the ligand is ﬂexible and charged. There is a sub-
stantial bias for escape routes near the atom which is being
pulled by the REMD force, but in a tight compartment the
ligand might exit with an atom far from the force application
site ﬁrst. Given more room, the molecule will most likely
rotate and exit with the pulled atom ﬁrst. The relative ori-
entation of the ligand in the exiting process is therefore
highly dependent of the REMD method.
CONCLUSIONS
RA exits the binding site of RAR mainly through the ﬂexible
region between the H1-H3 loop and the b-sheets. Interest-
ingly it may exit the binding pocket when H12 is bound to
the protein surface in its agonist position, indicating that
the popular ‘‘mouse trap’’ model is too simplistic to describe
the interactions between nuclear receptors and their agonist
ligands. The conformational selection model would be more
appropriate and describe both agonists and antagonists.
REMD is a powerful yet not fully developed method for
elucidating unbinding pathways. Here, we ﬁnd that applica-
tion of the REMD force to all ligand atoms (or the center of
mass) is generally preferred. This application mode gives the
most unbiased search for expulsion pathways, and the main
advantage of REMD is then fully utilized. For a ligand which
is tightly bound in the binding pocket through a strong elec-
trostatic interaction, application of the REMD force on a
single atom is preferred. The expulsion frequency will then
increase, although the resulting pathways are biased toward
the direction where the REMD force is applied.
Furthermore, we suggest that the problem of ﬁnding pos-
sible dissociation pathways is separated from the problem of
elucidating the force required for dissociation by applying
the REMD method to completely uncharged ligand models.
The magnitude of the REMD force is best determined by
systematic increments starting from a relatively low strength.
More studies are required to ﬁnd a general protocol for set-
ting the REMD parameters.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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